Adoptive transfer of virus-specific and tumor-specific T cell immunity
about
Immunology in the clinic review series; focus on cancer: double trouble for tumours: bi-functional and redirected T cells as effective cancer immunotherapiesProliferation-linked apoptosis of adoptively transferred T cells after IL-15 administration in macaquesAllogeneic lymphocyte-licensed DCs expand T cells with improved antitumor activity and resistance to oxidative stress and immunosuppressive factorsHow (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transferCytomegalovirus: pathogen, paradigm, and puzzleIdentification of novel MHC class I sequences in pig-tailed macaques by amplicon pyrosequencing and full-length cDNA cloning and sequencingEx vivo expansion of human CD8+ T cells using autologous CD4+ T cell helpAbrogating Cbl-b in effector CD8(+) T cells improves the efficacy of adoptive therapy of leukemia in mice.Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia.T cell stimulator cells, an efficient and versatile cellular system to assess the role of costimulatory ligands in the activation of human T cells.A panel of human cell-based artificial APC enables the expansion of long-lived antigen-specific CD4+ T cells restricted by prevalent HLA-DR alleles.A non-human primate model for analysis of safety, persistence, and function of adoptively transferred T cells.Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161(hi) CD8α⁺ semi-invariant T cellsMonoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans.Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection.Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotype.Immunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate "Natural" and "Inducible" CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer.Targeted cytotoxic therapy: adapting a rapidly progressing anticancer paradigm for depletion of persistent HIV-infected cell reservoirs.Cell-intrinsic abrogation of TGF-β signaling delays but does not prevent dysfunction of self/tumor-specific CD8 T cells in a murine model of autochthonous prostate cancerGene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-κB signaling improves the efficacy of immunotherapy in a brain cancer modelAbrogation of SRC homology region 2 domain-containing phosphatase 1 in tumor-specific T cells improves efficacy of adoptive immunotherapy by enhancing the effector function and accumulation of short-lived effector T cells in vivoTumour inflammasome-derived IL-1β recruits neutrophils and improves local recurrence-free survival in EBV-induced nasopharyngeal carcinomaComparison of naïve and central memory derived CD8(+) effector cell engraftment fitness and function following adoptive transfer.Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo.Adoptive Transfer of Engineered Rhesus Simian Immunodeficiency Virus-Specific CD8+ T Cells Reduces the Number of Transmitted/Founder Viruses Established in Rhesus MacaquesAdoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity.Establishment of antitumor memory in humans using in vitro-educated CD8+ T cells.Progress and prospects: graft-versus-host disease.An overview of sipuleucel-T: autologous cellular immunotherapy for prostate cancer.Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections.T-cell depleted allogeneic hematopoietic cell transplants as a platform for adoptive therapy with leukemia selective or virus-specific T-cells.Alanine Mutagenesis in the Complementarity Determining Region 3 of the MTB and HIV-1 Peptide-Bispecific T Cell Receptor Beta Chain Affects Ligand Recognition.Development of genetically engineered CD4+ and CD8+ T cells expressing TCRs specific for a M. tuberculosis 38-kDa antigen.Cytotoxic T lymphocytes promote cytarabine-induced acute myeloid leukemia cell apoptosis via inhibiting Bcl-2 expression.A registry of HLA-typed donors for production of virus-specific CD4 and CD8 T lymphocytes for adoptive reconstitution of immune-compromised patients.Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry.The potential association of CMV-specific CD8+ T lymphocyte reconstitution with the risk of CMV reactivation and persistency in post allogeneic stem cell transplant patients.Visualizing the dynamic of adoptively transferred T cells during the rejection of large established tumors.
P2860
Q27027243-C540DA4F-2E1A-4ECB-9F1C-79552F2B93CCQ27314843-5EAEA171-8B50-48B0-B9AD-638721BD0A9FQ28652288-537221B7-B562-413D-B7BA-AD3353A5BBECQ28727481-8FA7A744-3DC8-473D-94E8-431C74097F7CQ33351523-29FF54F1-F576-402F-B011-E584C7BD2C06Q33620953-2048BD92-7D67-4F85-A064-C68F4E141825Q34141754-AC269A4C-4F58-4B7F-A862-04BF11FD6AC0Q34162136-F33091BC-6EFF-43E8-8CF6-0C56970CEDCDQ34163218-8C29F1D7-C3CC-4BE8-9C0D-63F886F2EAF6Q34284626-B7DD0BC0-8870-4B11-9BA9-22BA9569E688Q34365057-52686894-6D74-4052-9479-9A84836C2428Q34625160-486BC5BE-3F78-49E5-91B1-4D6DBD26FBA8Q35212357-8E1FA56C-BBD2-4F04-BF6A-2840F11A975AQ35220386-A2B649D5-03FC-437B-82D7-02DFB3E46EA7Q35641516-9E90AC83-D351-4FB6-A7D5-9FAD505DCB76Q35849686-775B2891-0D5C-4C5C-A680-EB46212F250EQ35861249-3079CB0B-75C2-4D75-92F5-A3043EDFD914Q36073562-4C3C0F63-9C01-45D6-9B2C-54438096AAEAQ36303665-CE855410-EAF8-4B34-969F-9E1EDE6529B5Q36345439-B2D6EDD1-C7E8-4469-8954-0A76337C19D2Q36466018-24A9B847-7220-43C2-85A4-3F087C6C40E4Q36492390-B1291C7E-9586-4AFF-9D46-9858335A7C8BQ36597392-6B991F2A-DCDE-4DD5-9B7A-F0A7F12BA85CQ36743361-0928BDA4-6981-403C-A17F-E536F228C3EFQ37347373-0D8A2D52-806E-4F2B-8804-64016A525E11Q37389018-703C6B54-1861-4E5D-A142-2DC0657434D1Q37389364-B98F8337-9615-42CB-B3A4-F6FA43F868AAQ37761297-40524E47-8888-48F5-B7C1-738556754CD3Q37988725-9156C6EC-0884-4CAF-8D43-A0D271A51D1FQ38417056-97168CED-DF40-47EF-91A7-902F78DC21BAQ38514497-DB5E0C2E-6989-4637-91F5-0202AE93CBF5Q38598811-A852C495-17A4-4B14-9F95-33DBA997C372Q39752168-48A78BD8-7D37-4C2B-B6FA-376D97C6FFA8Q41115927-33D2129A-B8B6-44BB-840E-FA631F12EE0CQ42205114-C63A6DA4-58B0-45CE-83A2-40800C4BA5DCQ42271011-672A7299-E918-4407-A2A9-07892CB8C105Q47556784-F4A1070F-FD54-463E-B102-42AEEA71EE0FQ50993575-E4444A4A-9303-4246-A760-37C91A86A4EE
P2860
Adoptive transfer of virus-specific and tumor-specific T cell immunity
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Adoptive transfer of virus-specific and tumor-specific T cell immunity
@en
Adoptive transfer of virus-specific and tumor-specific T cell immunity.
@nl
type
label
Adoptive transfer of virus-specific and tumor-specific T cell immunity
@en
Adoptive transfer of virus-specific and tumor-specific T cell immunity.
@nl
prefLabel
Adoptive transfer of virus-specific and tumor-specific T cell immunity
@en
Adoptive transfer of virus-specific and tumor-specific T cell immunity.
@nl
P2093
P2860
P1476
Adoptive transfer of virus-specific and tumor-specific T cell immunity
@en
P2093
Cameron J Turtle
Carolina Berger
Michael C Jensen
Stanley R Riddell
P2860
P304
P356
10.1016/J.COI.2009.02.010
P577
2009-03-21T00:00:00Z